A Novel Insulin Sensitizer Drug Candidate—BGP-15—Can Prevent Metabolic Side Effects of Atypical Antipsychotics

201211 citationsJournal Articlegreen Open Access

Authors

Good health and well-being

Published in: Pathology & Oncology Research

Volume 18, Issue 4, pp. 1071-1076

Field-Weighted Citation Impact: 0.40